AEON
AEON Biopharma, Inc.
-0.02 (-7.47%)0.24USD1.2M成交股數11.9M市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q3 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 2.9M | 2.0M | 597K | 1.1M | 825K | 3.0M | 972K | 4.4M | 5.7M | 6.4M | – | 1.6M |
| 銷售管理費用 | 3.0M | 3.9M | 1.9M | 3.3M | 3.1M | 2.6M | 3.0M | 3.3M | 4.6M | 5.3M | – | 1.1M |
| 營業利益 | −5.9M+1181% | −5.9M+156% | −2.5M-38% | −4.3M-103% | −462K-99% | −2.3M-99% | −4.0M | 153M-5940% | −74.2M | −284M | – | −2.6M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −1.2M-113% | −11.8M-666% | −4.5M-26% | −6.6M-104% | 9.1M-108% | 2.1M-101% | −6.2M | 164M-693% | −118M | −298M | – | −27.7M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.02-101% | -0.29-104% | -0.39-97% | -0.60-100% | 2.28-101% | 8.04-200% | -11.24 | 304.00-152100% | -227.87 | -8.01 | – | -0.20 |
| 稀釋股數 | 50.5M | 40.6M | 11.6M | 11.1M | 4.0M | 576K | 549K | 540K | 518K | 37.2M | – | 139M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q3 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 3.4M | 6.2M | 5.9M | 8.4M | 10.4M | 13K | 537K | 3.4M | 1.6M | 16.2M | – | 31.2M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 5.9M | 8.6M | 8.7M | 11.7M | 13.8M | 3.1M | 4.0M | 5.7M | 3.0M | 17.6M | – | – |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 21.3M | 25.4M | 28.6M | 27.5M | 25.1M | 31.7M | 36.1M | 33.7M | 201M | 146M | – | – |
| 股東權益 | −15.4M | −16.8M | −19.9M | −15.9M | −11.3M | −28.6M | −32.1M | −27.9M | −198M | −128M | −311M | −311M |
| 負債比 | 359.9% | 294.1% | 327.5% | 235.9% | 182.1% | 1,009.3% | 901.4% | 587.4% | 6,642.9% | 828.7% | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q3 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −2.6M | – | – | −7.9M-8% | – | – | – | −8.6M | −15.1M | – | – |
| 資本支出 | – | – | – | – | 4K | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | −7.9M | – | – | – | – | – | – | – |
| 折舊攤銷 | – | 19K | – | – | 19K | – | – | – | 25K | 21K | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −39.2M | –% | -3.95 | −17.3M |
| FY2024 | – | – | 42.0M | –% | 72.93 | – |
| FY2022 | – | – | −52.6M | –% | -0.38 | −35.9M |
| FY2021 | – | – | 8.2M | –% | – | – |